Browse 6 Artificial Intelligence (AI) companies funded by OrbiMed. See funding amounts, founder contacts, and investment details.
DELFI's AI platform uses whole-genome sequencing to detect cancer-associated cfDNA fragmentation patterns in the blood.
Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.
Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.
MobileODT is an AI-based health-tech company that develops medical device technologies for cervical cancer screening.
View all companies funded by OrbiMed across every industry and funding stage.
View Full OrbiMed Portfolio